The vaccine pillar, combines CEPI’s leadership in vaccine development and investment in manufacturing with GAVI’s track record in revolutionizing access and delivery, and WHO’s oversight of regulation, policy and allocation.
4652
该支柱的作用是确保尽快开发出疫苗，在不影响安全性的情况下生产适当数量的疫苗，并将其交付给最需要者。
Its role is to ensure that vaccines are developed as rapidly as possible, manufactured at the right volumes without compromising on safety and delivered to those that need them most.
4653
目前的估计是，如果很快开发出一种安全有效的疫苗，到2021年底提供20亿剂疫苗将需要181亿美元。
The current estimate to deliver 2 billion doses by the end of 2021, assuming a safe and effectivevaccine is developed in the near future, is up to US$18.1 billion.
In addition, 950 million doses will need to be procured by self-financinghigh-income countries and upper middle-income countries through the COVAX Facility.
These numbers will become clearer once we get a better idea of, among other factors, the technology that the successful vaccine candidates will be based on and the number of doses required to protect people from COVID-19.
The health systems connector is the fourth pillar of the ACT-Accelerator and supports the other three by ensuring that health systems and local community networks can fully utilize these and other essential tools in their battle against COVID-19.
4658
这一支柱由世界银行和全球抗击艾滋病、结核病和疟疾基金牵头，并得到世卫组织支持。
This pillar is led by the World Bank and the Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM) and supported by the WHO.
It aims to build capacity – such as laboratory capacity, training for laboratory and health staff and management of protective equipment for health workers – needed to deploy the new tools effectively when they are ready.
It also works on system innovations to complement the rollout of products, such as contact tracing, social distancing and isolation approaches as well as community engagement needed to sustain them.